News | EP Lab | April 07, 2021

Broward Health Medical Center First in Florida to Adopt Robotic Ablation Technology to Treat Arrhythmias

The Stereotaxis Genesis Robotic Magnetic Navigation system.

The Stereotaxis Genesis Robotic Magnetic Navigation system.


April 7, 2021 — Stereotaxis announced that Broward Health Medical Center is establishing a robotic electrophysiology (EP) program to expand access to advanced minimally-invasive treatment of heart rhythm disorders in Florida. Broward will be the only hospital in South Florida offering robotic technology to treat patients suffering from arrhythmias and is the first in Florida, and among the first in the nation, to adopt the latest Genesis Robotic Magnetic Navigation system.

“The adoption of this advanced robotic technology further reinforces the commitment Broward Health Medical Center has toward providing high quality cardiac care for patients suffering from all types of arrhythmias,” said Ahmed Osman, M.D., medical director of the cardiac electrophysiology lab. “This technology helps enhance the reach, precision and stability of the traditional tools used in ablation therapy, while having inherent attributes that can increase safety. We are very excited to have access to this technology for our patients.”

Stereotaxis robotic magnetic navigation introduces the benefits of robotic precision and safety to what are often long cardiac ablation procedures.

“On the heels of Broward Health Medical Center’s recent IAC accreditation for electrophysiology, we are excited to bring this latest technology to our complex arrhythmia program,” said Heather Havericak, CEO of Broward Health Medical Center. “Studies suggest that one in four Americans over the age of 40 could develop irregular heartbeats, and over 2.3 million Americans suffer from atrial fibrillation. The adoption of Robotic Magnetic Navigation supports our commitment to providing comprehensive cardiac care for our community and the greater tri-county area.”

“We are delighted to partner with Broward Health to help enhance quality of care and access to therapy for patients in Florida,” said David Fischel, chairman and CEO of Stereotaxis. “We applaud their leadership and look forward to supporting their efforts to build a preeminent heart rhythm program in the region.”

For more information: www.stereotaxis.com
 

Related EP Robotic Systems Content:

VIDEO: Virtual Tour of the Robotic Electrophysiology Lab at Banner Health — Interview with Peter Weiss, M.D.

Stereotaxis Announces Next-generation Robotic Magnetic Navigation and Imaging Systems

VIDEO: Advantages of Robotic Ablation in the EP Lab — Interview with Peter Weiss, M.D.

Time to Take Another Look at Robotics in Electrophysiology — Article by Peter Weiss, M.D.

Stereotaxis and Acutus Medical Announce Strategic Collaboration
 

Find more news on robotic cath lab and EP lab systems


Related Content

News

Jan. 20, 2026 — Abbott has received CE Mark in Europe for the TactiFlex Duo Ablation Catheter, Sensor Enabled to treat ...

Home January 22, 2026
Home
News

Jan. 20, 2026 — Kardium Inc. has announced the publication of the PULSAR clinical trial results in the Journal of the ...

Home January 21, 2026
Home
Feature | Kyle Hardner

Robotic Magnetic Navigation (RMN) emerged two decades ago as an alternative approach to performing complex ablation ...

Home January 09, 2026
Home
News

Jan. 6, 2026 — Stereotaxis, a supplier of surgical robotics for minimally invasive endovascular intervention, has ...

Home January 06, 2026
Home
News

Oct. 10, 2025 — Johnson & Johnson MedTech, in collaboration with the Heart Rhythm Clinical and Research Solutions, LLC ...

Home October 13, 2025
Home
News

Sept. 2, 2025 — Johnson & Johnson MedTech has announced acute safety and effectiveness results from the Varipure ...

Home September 05, 2025
Home
News

Sept. 3, 2025 — Kardium Inc. recently announced it has received pre-market approval (PMA) for the Globe Pulsed Field ...

Home September 03, 2025
Home
News

July 14, 2025  –  Johnson & Johnson MedTech has announced U.S. Food and Drug Administration (FDA) approval of an update ...

Home July 14, 2025
Home
News

July 7, 2025 — Catheter ablation is a minimally invasive treatment for abnormal heart rhythms. It is often successful in ...

Home July 09, 2025
Home
News

June 4, 2025 — A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons ...

Home June 04, 2025
Home
Subscribe Now